Zhejiang Huahai Pharmaceutical (600521.SH) has adjusted the size of the private placement fundraising to not exceed 600 million yuan.

Zhejiang Huahai Pharmaceutical (600521.SH) announced that, in accordance with relevant laws, regulations, and normative documents, and considering changes in the current market environment and the actual situation of the company, the company has adjusted the fundraising scale for the issuance of shares to specific targets. The fundraising scale has been adjusted from not more than 1.21 billion yuan (including the total number) to not more than 600 million yuan (including the total number), and the corresponding investment projects for the fundraising amount have been adjusted accordingly. Apart from the above adjustments, there are no other changes in the company's plan for issuing shares to specific targets this time.